Risks of SARS-CoV-2 JN.1 Infection and COVID-19–Associated Emergency-Department Visits or Hospitalizations Following Updated Boosters and Prior Infection
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risks of SARS-CoV-2 JN.1 infection and COVID-19 associated emergency-department (ED) visits/hospitalizations following updated boosters and prior infection: a population-based cohort study
Clin. Infect. Dis. 2024 Jun 26;[EPub Ahead of Print], C Chong, LE Wee, X Jin, M Zhang, MIA Malek, B Ong, D Lye, CJ Chiew, KB TanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.